Provided by Tiger Trade Technology Pte. Ltd.

ATI Inc

140.43
-3.5100-2.44%
Post-market: 139.90-0.5300-0.38%19:35 EDT
Volume:1.50M
Turnover:211.31M
Market Cap:19.23B
PE:49.27
High:143.50
Open:141.90
Low:139.94
Close:143.94
52wk High:168.14
52wk Low:39.23
Shares:136.94M
Float Shares:134.00M
Volume Ratio:0.62
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.85
EPS(LYR):2.85
ROE:21.62%
ROA:7.96%
PB:10.66
PE(LYR):49.27

Loading ...

Deutsche Bank Adjusts ATI Price Target to $150 From $139, Maintains Buy Rating

MT Newswires Live
·
Feb 04

ATI price target raised to $150 from $135 at JPMorgan

TIPRANKS
·
Feb 04

ATI : Deutsche Bank Raises Target Price to $150 From $139

THOMSON REUTERS
·
Feb 04

ATI Is Maintained at Buy by BTIG

Dow Jones
·
Feb 04

ATI: Differentiated Aerospace Supplier with Expanding Margins and Above-Consensus Outlook Justifies Buy Rating

TIPRANKS
·
Feb 04

U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico

Reuters
·
Feb 04

ATI Inc. Earnings Call Highlights Aerospace-Fueled Surge

TIPRANKS
·
Feb 04

ATI Inc. Shares Soar on Strong Q4 Results and Raised FY2026 EPS Guidance

Deep News
·
Feb 04

Stock Track | ATI Inc Soars 5.42% in Pre-market on Q4 Earnings Beat and Strong FY2026 Guidance

Stock Track
·
Feb 03

Stock Track | ATI Inc Soars 5.12% in Pre-market on Q4 Earnings Beat and Strong FY2026 Guidance

Stock Track
·
Feb 03

GUIDANCE: (ATI) ATI Expects Fiscal 2026 Adjusted EPS Range $3.99 - $4.27, vs. FactSet Est of $3.89

MT Newswires Live
·
Feb 03

ATI reports Q4 adjusted EPS 93c, consensus 87c

TIPRANKS
·
Feb 03

ATI sees Q1 adjusted EPS 83c-89c, consensus 87c

TIPRANKS
·
Feb 03

ATI Q4 Adj. EPS $0.93 Beats $0.88 Estimate, Sales $1.177B Miss $1.187B Estimate

Benzinga
·
Feb 03

ATI Q4 EPS USD 0.69

THOMSON REUTERS
·
Feb 03

U.S. Earnings Preview: Before Market Open Feb. 3

Dow Jones
·
Feb 03

Top News Today/Canada: Manufacturing Sector Steadies; Eldorado to Buy Foran

Dow Jones
·
Feb 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 02

Aclaris Therapeutics reports ‘positive’ results from ATI-2138

TIPRANKS
·
Jan 27

Aclaris Therapeutics’ Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)

GlobeNewswire
·
Jan 27